Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells.

Abstract : High throughput DNA microarray has made it possible to outline genes whose expression in malignant plasma cells is associated with short overall survival of patients with Multiple Myeloma (MM). A further step is to elucidate the mechanisms encoded by these genes yielding to drug resistance and/or patients' short survival. We focus here on the biological role of the DEP (for Disheveled, EGL-10, Pleckstrin) domain contained protein 1A (DEPDC1A), a poorly known protein encoded by DEPDC1A gene, whose high expression in malignant plasma cells is associated with short survival of patients. Using conditional lentiviral vector delivery of DEPDC1A shRNA, we report that DEPDC1A knockdown delayed the growth of human myeloma cell lines (HMCLs), with a block in G2 phase of the cell cycle, p53 phosphorylation and stabilization, and p21(Cip1) accumulation. DEPDC1A knockdown also resulted in increased expression of mature plasma cell markers, including CXCR4, IL6-R and CD38. Thus DEPDC1A could contribute to the plasmablast features of MMCs found in some patients with adverse prognosis, blocking the differentiation of malignant plasma cells and promoting cell cycle.
Type de document :
Article dans une revue
PLoS ONE, Public Library of Science, 2013, 8 (4), pp.e62752. 〈10.1371/journal.pone.0062752〉
Liste complète des métadonnées

Littérature citée [44 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00840268
Contributeur : Monique Frei <>
Soumis le : mardi 2 juillet 2013 - 10:16:42
Dernière modification le : vendredi 20 octobre 2017 - 01:17:30
Document(s) archivé(s) le : mercredi 5 avril 2017 - 05:56:19

Fichier

journal.pone.0062752_2013.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Alboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, Jean-Luc Veyrune, Thierry Rème, et al.. Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells.. PLoS ONE, Public Library of Science, 2013, 8 (4), pp.e62752. 〈10.1371/journal.pone.0062752〉. 〈inserm-00840268〉

Partager

Métriques

Consultations de la notice

500

Téléchargements de fichiers

215